StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.50−0.20 (-11.76%)

Close on Nov 17, 2026Market cap $12.22MP/E –Yield –

Niki BioSolutions enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Niki BioSolutions's enterprise value was -$1.28M on Nov 11, 2026, against $61.98M a year earlier. Over the last 5 years it ranged from -$1.28M to $570.76M, with a median of $74.29M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.28M-102.8%
2025Dec 31, 2025$46.16M-60.3%
2024Dec 31, 2024$116.33M+49.1%
2023Dec 29, 2023$78.00M-57.1%
2022Dec 30, 2022$181.95M-59.4%
2021Dec 31, 2021$448.21M-36.9%
2020Dec 31, 2020$710.10M-83.9%
2019Dec 31, 2019$4.40B–

More Niki BioSolutions figures

See a number that looks wrong?